NCT00051623View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

June 30, 2004

Conditions
Arthritis, Psoriatic
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY